Eva Hertervig
1 – 5 of 39
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE) : a multicentre, open-label, randomised controlled trial
(
- Contribution to journal › Article
- 2021
-
Mark
Clinical effectiveness of golimumab in ulcerative colitis : a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG
(
- Contribution to journal › Article
- 2017
-
Mark
Long-term outcome of infliximab treatment in chronic active ulcerative colitis : a Swedish multicentre study of 250 patients
(
- Contribution to journal › Article
-
Mark
Long-term outcomes of the current remote magnetic catheter navigation technique for ablation of atrial fibrillation
(
- Contribution to journal › Article
-
Mark
Letter: how to define remission in ulcerative colitis – histological remission should be considered. Authors' reply
(
- Contribution to journal › Letter